diagnosi
possibl
deep
sequenc
brain
biopsi
sequenc
comparison
vaccin
batch
muv
isol
brain
identifi
bias
hypermut
particularli
matrix
gene
similar
found
measl
case
sspe
find
provid
uniqu
insight
pathogenesi
paramyxoviru
brain
infect
chronic
enceph
progress
loss
motor
cognit
function
high
level
intrathec
antibodi
associ
persist
measl
rubella
infect
brain
commonli
context
abstract
routin
childhood
vaccin
measl
mump
rubella
virtual
abolish
virusrel
morbid
mortal
notwithstand
describ
devast
neurolog
complic
associ
detect
liveattenu
mump
viru
jeryl
lynn
muv
brain
child
undergon
success
allogen
transplant
sever
combin
immunodefici
scid
first
confirm
report
muv
associ
chronic
enceph
highlight
need
exclud
immunodefici
individu
immunis
liveattenu
vaccin
electron
supplementari
materi
onlin
version
articl
contain
supplementari
materi
avail
author
user
subacut
scleros
panenceph
sspe
describ
case
chronic
panenceph
child
undergon
success
allogen
haematopoiet
stem
cell
transplant
allosct
sever
combin
immunodefici
scid
neither
measl
pathogen
could
detect
use
deep
sequenc
fresh
brain
biopsi
materi
identifi
jeryl
lynn
mump
viru
muv
compon
measl
mump
rubella
mmr
vaccin
administ
child
diagnosi
scid
similar
find
measl
virus
recov
case
sspe
mump
viru
genom
brain
show
evid
bias
hypermut
particularli
matrix
gene
comparison
sequenc
data
origin
vaccin
batch
use
immunis
child
identifi
expans
variant
present
low
frequenc
vaccin
well
de
novo
fix
missens
substitut
case
repres
first
conclus
demonstr
chronic
panenceph
due
mump
viru
male
infant
consanguin
parent
diagnos
scid
due
recombinas
activ
gene
defici
fig
month
mmr
vaccin
infant
receiv
haploident
allosct
full
donor
chimer
rapidli
achiev
recoveri
divers
cell
repertoir
fig
excel
thymopoiesi
posttranspl
autoimmun
cytopenia
necessit
rituximab
therapi
follow
immunoglobulin
replac
therapi
administ
six
month
postallosct
child
develop
febril
ill
rash
diarrhoea
lethargi
seizur
evid
enceph
magnet
reson
imag
mri
rais
csf
protein
gl
lymphocyt
despit
extens
screen
neurotrop
virus
bacteria
tabl
pathogen
detect
treat
antimicrobi
antivir
steroid
make
good
recoveri
discharg
anticonvuls
therapi
next
month
child
note
behaviour
problem
hear
impair
speech
languag
delay
one
year
discharg
seizur
recur
partial
respons
antiepilept
treatment
remain
stabl
anoth
month
repeat
mri
scan
year
initi
encephalit
ill
show
new
lesion
next
month
child
neurolog
condit
deterior
increas
seizur
togeth
episod
lethargi
disorient
agit
atax
gait
visual
loss
eventu
hospitalis
repeat
mri
brain
month
postallosct
reveal
abnorm
grey
white
matter
involv
cerebr
hemispher
multipl
foci
contrast
enhanc
includ
basal
ganglia
tempor
parietooccipit
cortic
fig
absenc
firm
diagnosi
brain
biopsi
taken
broadspectrum
antibiot
aciclovir
ganciclovir
antifung
therapi
administ
well
intraven
immunoglobulin
ivig
highdos
methyl
prednisolon
increas
seizur
leftsid
weak
cortic
blind
progress
global
neurolog
deterior
sever
week
end
patient
death
week
follow
last
hospit
admiss
virus
list
tabl
test
use
realtim
pcr
found
neg
use
specif
primer
taqman
probe
abi
thermocycl
pcr
assay
perform
inhous
gosh
great
ormond
street
hospit
children
london
part
routin
diagnost
servic
unless
indic
otherwis
case
sent
differ
laboratori
test
csf
urin
sampl
collect
patient
last
hospitalis
well
rna
reextract
brain
biopsi
sent
public
health
england
viru
refer
laboratori
colindal
mump
mump
vaccinespecif
rtpcr
target
sh
hn
gene
well
measl
rubellaspecif
rtpcr
total
rna
purifi
frozen
brain
biopsi
polya
rnasepar
sequenc
librari
prepar
sampl
sequenc
illumina
instrument
illumina
san
diego
us
use
bp
pairedend
run
librari
multiplex
run
pool
equimolar
quantiti
calcul
qpcr
andor
bioanalys
fragment
analysi
sampl
process
use
illumina
truseq
strand
mrna
lt
sampl
prepar
kit
pn
accord
manufactur
instruct
deviat
protocol
follow
ng
total
rna
use
start
materi
fragment
carri
min
instead
min
cycl
pcr
use
briefli
mrna
isol
total
rna
use
oligo
dt
bead
pull
polyadenyl
transcript
purifi
mrna
fragment
use
chemic
fragment
heat
dival
metal
cation
prime
random
hexam
strandspecif
firststrand
cdna
gener
use
superscript
ii
revers
transcriptas
life
technolog
actinomycin
allow
rnadepend
synthesi
prevent
spuriou
dnadepend
synthesi
second
cdna
strand
mark
perform
synthesi
incorpor
dutp
cdna
atail
end
prevent
selflig
addit
fulllength
truseq
adaptor
adaptor
complementari
overhang
adaptor
contain
sequenc
allow
librari
amplifi
pcr
bind
flow
cell
uniqu
identifi
way
bp
index
sequenc
final
pcr
carri
amplifi
cdna
fragment
adaptor
bound
end
archiv
vial
batch
mmr
vaccin
use
immunis
child
deep
sequenc
pairedend
sequenc
illumina
miseq
part
pool
gener
read
pair
nation
institut
biolog
standard
control
nibsc
lyophilis
vaccin
resuspend
steril
water
inject
viral
rna
extract
use
qiaamp
viral
rna
mini
spin
kit
qiagen
accord
method
manufactur
omiss
carrier
rna
dna
librari
prepar
random
reversetranscriptas
polymeras
chain
reaction
describ
previous
follow
fragment
adaptor
addit
index
use
nextera
xt
librari
prepar
kit
illumina
formalinfix
paraffinembed
section
brain
biopsi
examin
convent
histolog
immunohistochemistri
undertaken
use
two
differ
antibodi
two
independ
laboratori
immunohistochemistri
undertaken
use
mump
nucleoprotein
n
antibodi
santa
cruz
use
leica
bond
max
autom
stain
system
pretreat
hier
addit
immunohistochemistri
independ
undertaken
use
differ
antibodi
monoclon
mump
antibodi
use
recognis
n
protein
muv
use
autom
leica
bondmax
immunostain
dilut
follow
pretreat
min
detect
site
detect
polymerbas
detect
system
bond
newcastl
upon
tyne
uk
cat
detect
mump
n
cn
immunohistochemistri
shown
figur
analysi
brain
biopsi
sequenc
data
implement
follow
step
first
remov
duplic
sequenc
aris
pcr
amplif
inhous
script
collaps
pair
read
base
sequenc
ident
use
sequenc
signatur
remov
duplic
half
read
overlap
mate
within
pair
therefor
merg
overlap
read
use
pear
take
account
sequenc
match
qualiti
score
perform
qualiti
control
use
prinseq
trim
lowqual
end
remov
read
averag
qualiti
less
subsequ
remov
human
sequenc
use
quick
align
novoalign
version
refer
genom
well
blastn
perform
de
novo
assembl
highqual
contig
use
velvet
kmer
final
annot
contig
unassembl
read
custom
protein
refer
databas
use
blastx
custom
protein
refer
databas
consist
viral
bacteri
human
mous
refseq
protein
specif
known
virus
refseq
collect
use
ftp
ftpncbinlmnihgov
well
bacteria
human
microbiom
accord
ftp
ftp
ncbinihgovgenomeshumanmicrobiombacteria
allfaatargz
blastx
result
input
metamix
analysi
vaccin
sequenc
first
remov
read
duplic
merg
overlap
read
trim
read
base
base
qualiti
q
use
trim
galor
http
wwwbioinformat
babrahamacukprojectstrimgalor
select
jeryl
lynn
vaccin
strain
read
use
blastn
jeryl
lynn
nucleotid
refer
databas
perform
de
novo
assembl
spade
follow
quast
vaccin
brain
sequenc
data
latter
case
use
muv
read
identifi
metamix
novoalign
samtool
use
consensu
sequenc
gener
variant
call
filter
variant
base
qualiti
depth
frequenc
strand
bia
qualiti
least
read
variant
site
frequenc
p
valu
variant
annot
snpeff
compar
number
nonsynonym
chang
observ
muv
gene
number
would
expect
observ
missens
mutat
randomli
distribut
across
genom
correct
gene
length
signific
deviat
expect
number
mutat
test
goodnessoffit
twotail
exact
binomi
test
analysi
conduct
statist
languag
r
http
wwwrprojectorg
estim
maximum
likelihood
phylogenet
tree
use
raxml
full
muv
genom
genbank
access
june
csf
last
admiss
acellular
oligoclon
band
although
total
protein
low
gl
normal
gl
oligoclon
band
neg
hsv
vzv
antibodi
polyoma
jc
viru
detect
pcr
blood
urin
one
occas
tabl
csf
pcr
neg
bacteri
fungal
rrna
wide
number
viral
pathogen
tabl
includ
jc
viru
mump
measl
rubella
virus
pathogen
detect
stool
urin
blood
tabl
csf
neg
rubella
measl
antibodi
absenc
firm
diagnosi
brain
biopsi
show
neuron
loss
astrocyt
gliosi
reactiv
astrocyt
microglia
chronic
inflammatori
cell
viral
inclus
granulomata
fig
e
legend
detail
descript
infiltr
lymphocyt
identifi
stain
fig
rnaseq
brain
biopsi
result
million
base
pair
bp
pairedend
read
approxim
one
million
read
identifi
nonhuman
subsequ
use
potenti
pathogen
identif
metamix
method
mump
viru
potenti
pathogen
detect
assign
read
remain
read
either
unclassifi
map
human
bacteria
either
environment
part
human
flora
kit
contamin
unknown
signific
tabl
read
map
measl
rubella
polyoma
jc
virus
use
de
novo
assembl
fulllength
viral
sequenc
recov
genom
coverag
median
coverag
depth
figur
maximum
likelihood
phylogenet
analysi
show
consensu
viral
sequenc
cluster
close
muv
vaccin
strain
figur
share
ident
publicli
avail
sequenc
genbank
mump
compon
mmr
prepar
administ
child
sequenc
identifi
studi
name
muv
london
genbank
pcr
rna
extract
brain
biopsi
confirm
presenc
muv
vaccin
strain
tabl
neg
virus
includ
polyoma
jc
tabl
immunohistochemistri
show
presenc
muv
nucleocapsid
n
protein
neuron
pattern
stain
fig
h
control
cortex
white
matter
neg
observ
specif
stain
pathogen
fig
h
detail
evid
viral
intracytoplasm
intranuclear
inclus
bodi
retrospect
test
show
weakli
posit
mump
antibodi
csf
investig
find
three
million
bp
pairedend
read
gener
mmr
vaccin
batch
use
immunis
child
read
map
muv
vaccin
strain
median
coverag
figur
fix
differ
identifi
compar
refer
fifteen
posit
vaccin
sequenc
found
polymorph
variant
allel
frequenc
vaf
greater
tabl
fix
nucleotid
differ
muv
london
vaccin
present
minor
variant
vaccin
figur
tabl
vaf
greater
remain
new
mutat
code
missens
amino
acid
substitut
fig
tabl
nine
locat
protein
expect
chanc
twotail
exact
binomi
test
p
tabl
posit
protein
missens
mutat
uniqu
muv
london
figur
substitut
muv
london
found
wildtyp
strain
well
neurovirul
muv
ur
urab
muv
jeryl
lynn
vaccin
strain
minor
compon
vaccin
figur
prior
introduct
routin
mmr
vaccin
mump
viru
commonest
caus
meningoenceph
children
associ
seriou
sequela
includ
deaf
orchiti
meningoenceph
confirm
follow
jeryl
lynn
mump
vaccin
child
receiv
advers
effect
rare
usual
selflimit
mump
rubella
vaccin
viru
transcript
detect
brain
child
defici
develop
fatal
enceph
follow
mmr
vaccin
brain
immunohistochemistri
neg
case
jb
person
commun
present
case
share
featur
two
previous
publish
case
muvrel
progress
enceph
moreov
like
measl
sspe
measl
inclus
bodi
enceph
mibe
occur
immunocompromis
children
within
month
measl
infect
vaccin
unlik
acut
muv
enceph
viru
detect
csf
howev
hallmark
sspe
mibe
high
virusspecif
antibodi
level
csf
absent
although
child
defici
b
cell
function
importantli
howev
comparison
muv
vaccin
batch
use
immunis
child
muv
london
show
evid
c
bias
hypermut
particularli
matrix
gene
suggest
adenosin
deaminas
adar
driven
mutat
tabl
find
mv
recov
sspe
mibe
fig
much
cortex
show
signific
tissu
damag
neuron
loss
promin
reactiv
gliosi
compos
plump
astrocytosi
abund
eosinophil
cytoplasm
immunoreact
glial
fibrillari
acid
protein
gfap
e
rel
spare
superfici
layer
cortex
area
show
perivascular
lymphocytosi
collect
macrophag
c
other
better
neuron
preserv
foci
microgli
nodul
neuronophagia
generalis
microgliosi
demonstr
stain
b
patchi
parenchym
perivascular
lymphocyt
major
posit
cell
marker
f
occasion
foci
mineralis
observ
vascul
viral
inclus
patholog
chang
extend
underli
white
matter
data
shown
show
patchi
loss
myelin
stain
luxol
fast
blue
focal
chronic
inflamm
leptomening
mump
immunohistochemistri
posit
neuron
pattern
g
h
observ
specif
stain
pathogen
cmv
ebv
toxoplasma
jc
viru
bacteria
gram
gram
twort
acidfast
bacteria
ziehlneelson
fungi
grocott
evid
intracellular
intranuclear
viral
inclus
bodi
b
haematoxylin
eosin
h
e
c
immunohistochemistri
e
gfap
immunohistochemistri
f
immunohistochemistri
scale
barsb
h
c
shown
reduc
protein
express
moot
promot
cell
cell
spread
reduc
viral
assembl
shed
csf
bias
hypermut
lack
protein
express
may
also
reflect
dispens
protein
neurovirul
muv
london
characteris
expans
variant
present
low
frequenc
origin
vaccin
two
previous
describ
well
fix
de
novo
mutat
n
p
l
f
gene
find
refer
describ
mv
sspe
amino
acid
substitut
occur
gene
vitro
data
use
rat
model
implic
f
protein
key
mump
viru
neurovirul
acut
enceph
well
measl
neurovirul
sspe
absenc
withinhost
sequenc
divers
f
orf
figur
tabl
suggest
function
constraint
gene
support
direct
select
act
one
amino
acid
chang
protein
favour
spread
replic
muv
brain
child
clinic
deterior
occur
follow
good
cell
reconstitut
context
normal
cell
receptor
repertoir
good
level
thymopoiesi
one
possibl
presenc
mump
toleris
dysregul
cell
respons
thu
permit
longterm
viral
persist
accumul
pathogen
mutat
made
use
data
donor
hla
genotyp
predict
specif
ctl
cell
epitop
iedb
epitop
predict
tool
percentil
rank
cutoff
muv
mump
vaccin
viru
five
missens
mutat
locat
predict
ctl
epitop
donor
hla
fig
tabl
four
predict
cell
bind
affin
level
like
correl
cell
recognit
reduc
bind
affin
mutat
peptid
tabl
rais
possibl
partial
escap
viru
immun
surveil
specif
mutat
chang
may
occur
especi
observ
peptid
recognis
randomli
select
hla
allel
supplementari
appendix
tabl
summari
report
case
progress
chronic
enceph
patient
scid
muv
vaccin
strain
detect
brain
biopsi
deep
sequenc
case
emphasis
gener
poor
rate
pathogen
detect
encephalitid
make
strong
case
deep
sequenc
brain
tissu
method
fail
similar
pattern
viral
mutat
case
measl
sspe
suggest
common
pathogen
process
work
current
underway
determin
contribut
fix
mutat
chronic
encephalit
phenotyp
observ
patient
import
note
mmr
continu
highli
effect
safe
vaccin
vast
major
individu
howev
case
highlight
import
develop
strategi
newborn
screen
exclud
small
proport
infant
extrem
high
risk
complic
liveattenu
vaccin
tabl
toni
brook
ucl
genom
sequenc
servic
financi
disclosur
work
support
nation
institut
health
research
nihr
biomed
research
centr
brc
great
ormond
street
hospit
children
nh
foundat
trust
gosh
univers
colleg
london
sm
fund
pathseek
j
brown
support
nihr
fellowship
goshucl
brc
wpd
receiv
grant
fund
nih
tj
receiv
fund
gosh
children
chariti
brain
tumour
chariti
children
cancer
gosh
ich
biomed
research
centr
wq
receiv
grant
fund
nihr
gosh
chariti
goshucl
brc
jb
receiv
fund
nihr
brc
univers
colleg
london
hospit
uclh
ucl
remain
author
noth
disclos
open
access
articl
distribut
term
creativ
common
attribut
intern
licens
http
permit
unrestrict
use
distribut
reproduct
medium
provid
give
appropri
credit
origin
author
sourc
provid
link
creativ
common
licens
indic
chang
made
